InvestorsHub Logo
Followers 4
Posts 409
Boards Moderated 0
Alias Born 10/28/2009

Re: None

Tuesday, 12/01/2015 1:06:21 PM

Tuesday, December 01, 2015 1:06:21 PM

Post# of 32013
Rebalancing Buy? 2 M shares tonight?
really?
http://247wallst.com/healthcare-business/2015/12/01/huge-powershares-etf-rebalance-means-massive-buying-for-4-biotech-stocks/


MannKind

MannKind Corp. (NASDAQ: MNKD) focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes, and Cowen thinks it will see a massive buy of 2,405,300 shares of stock. That represents 41% of the 10-day average trading volume.

The company has been an incredibly volatile stock over the past few years. MannKind has launched its inhalable insulin product, which was on the burner seemingly forever.

The consensus price target is set at $4.67. MannKind shares closed trading on Monday at $2.


If it really happens it could be my short squeeze.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News